Christopher Gamper, M.D., Ph.D., assistant professor of pediatric oncology at the Johns Hopkins Kimmel Cancer Center, has been named a St. Baldrick’s Scholar by the St. Baldrick’s Foundation. Gamper, a physician-scientist who treats children with cancer and studies x in the lab, will receive $330,000 to examine the function of T cells that lack the ability to methylate DNA; such cells may be better at killing tumors. This may help more patients with high-risk pediatric tumors, and decrease the risk of late-effects by reducing the need for more chemotherapy and radiation.
Rachel Rau, M.D., pediatric oncology fellow in the Division of the Johns Hopkins Kimmel Cancer Center, has received a $203,318 grant to study two mutations that occur together frequently in AML -- mutations in a gene called nucleophosmin and a gene called Flt3. Her research will examine the relationship between these two gene mutations, to gain insight into the cause of leukemia and how best to treat patients who have these two common genes.
Eric Raabe, M.D., pediatric oncology fellow in the Division of the Johns Hopkins Kimmel Cancer Center, has received a $30,546 grant to study the process of how a neural stem cell turns into a normal brain cell, and investigating how to reprogram the out-of-control tumor cells into mature cells, to help to prevent and eradicate pediatric brain tumors.